fda reconsiders tirzepatide FDA's Weight Loss Drug 'No Man's Land' Adds Risk for Compounders The FDA Can't Decide Whether

Better Focus Reduce brain fog and stay mentally on point

Majumder S, Deen MJ

Identifying additional benefits could help us understand the biological pathways influenced by these drugs and uncover new opportunities for disease prevention and treatment, including cancer prevention. Aparna Kamat, MD Kamat is the senior author of a new study published in the journal Annals of Oncology that found a potential link between taking GLP-1 medications, such as Ozempic , Wegovy , Zepbound , and Mounjaro , and a decrease in the overall risk of developing obesity-related cancers in people without diabetes

doi: 10.1007/s13224-019-01251-1 87 CalogeroAGulloGLa VigneraSCondorelliRVaiarelliA

Waist circumference, strength, adherence and side effects matter too